ClinicalTrials.Veeva

Menu

Analgesic Efficacy of Different Volumes in Erector Spinae Plane Block in Single Level Lumbar Spine Fixation

K

Kafrelsheikh University

Status and phase

Completed
Phase 4

Conditions

Analgesia

Treatments

Drug: Bupivacaine 0.25% Injectable Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT05892887
MKSU 50- 1 - 10

Details and patient eligibility

About

The analgesic efficacy of different volumes in ESPB patients undergoing single-level lumbar spine fixation

Full description

The erector spinae plane block (ESPB) its an interfacial plane block for an effective treatment for thoracic neuropathic pain. Currently, compared to the use of opioids, the ESPB has fewer side effects and is safe for patients of all ages having abdominal and thoracic operations .

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18-65 years.
  2. Both genders.
  3. American Society of Anesthesiologists' (ASA) physical status I or II.
  4. Undergoing single level lumbar spine fixation.

Exclusion criteria

  1. Patient refusal.
  2. Pregnant females.
  3. Renal, lung, heart, or liver disorders.
  4. Communication difficulties which might prevent a reliable postoperative assessment.
  5. Contraindication to regional anesthesia (bleeding disorder, use of any anticoagulants, local infection, known allergy to local anesthetics).
  6. BMI more than 30 kg/m2.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

Erector 10
Experimental group
Description:
Received 10ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side
Treatment:
Drug: Bupivacaine 0.25% Injectable Solution
Erector 15
Experimental group
Description:
Received 15ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side
Treatment:
Drug: Bupivacaine 0.25% Injectable Solution
Erector 20
Experimental group
Description:
Received 20ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side
Treatment:
Drug: Bupivacaine 0.25% Injectable Solution

Trial contacts and locations

1

Loading...

Central trial contact

Mohammad Fouad Algyar, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems